Evolus Company Description

Evolus, Inc., a performance beauty company, focuses on delivering products in the cash-pay aesthetic market in the United States, Canada, and Europe.

The company offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Nuceiva, for the temporary improvement in the appearance of moderate to severe vertical lines between the eyebrows seen at maximum frown.

It also provides dermal filler products under the Estyme and Evolysse names. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

Evolus, Inc.

Country	United States
Founded	2012
Industry	Medical - Pharmaceuticals
Sector	Healthcare
Employees	273
CEO	David Moatazedi

Contact Details

Address: 520 Newport Center Drive Newport Beach, Delaware 92660 United States
Phone	949 284 4555
Website	evolus.com

Stock Details

Ticker Symbol	0K16
Exchange	London Stock Exchange
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	USD
ISIN Number	US30052C1071
SIC Code	2834

Key Executives

Name	Position
David Moatazedi	Chief Executive Officer
Sandra Beaver	Chief Financial Officer
Nareg Sagherian	Head of Investor Relations